• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病住院患者无法进食时基础胰岛素剂量减少的评估

Evaluation of Basal Insulin Dose Reductions in Hospitalized Patients With Diabetes While Unable to Eat.

作者信息

Petite Sarah E, Huenecke Joseph, Tuttle Natalie

机构信息

The University of Toledo, OH, USA.

Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Hosp Pharm. 2020 Aug;55(4):246-252. doi: 10.1177/0018578719841029. Epub 2019 Apr 8.

DOI:10.1177/0018578719841029
PMID:32742013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7370343/
Abstract

The American Diabetes Association guidelines recommend a basal plus correction or basal insulin regimen for patients with type 2 diabetes mellitus (T2DM) receiving nothing by mouth (NPO; nil per os) in the non-intensive care unit setting. In the perioperative setting, 60% to 80% of long-acting insulin or half-dose morning insulin NPH is recommended. The goal of this study was to determine the impact of basal insulin dose reduction for hospitalized patients with insulin-dependent T2DM while NPO. This retrospective, single-center study evaluated patients admitted to the non-intensive care unit setting. Administration of >50% of home basal insulin was compared with administration of ≤50% of home basal insulin. The primary outcome was the difference in hypoglycemic events (blood glucose [BG] < 70 mg/dL). Secondary outcomes included comparing severe hypoglycemic events (BG < 40 mg/dL), hyperglycemic events (BG > 180 mg/dL), and hospital length of stay (LOS). Two hundred fifty-eight patient encounters were included, of which 85 and 173 patients received ≤50% and >50% of their home basal insulin dose, respectively. There were no significant differences in hypoglycemia (21.2% vs 21.4%; = .97), severe hypoglycemia (1.2% vs 2.9%; = .67), and hospital LOS (3 [IQR 2.13-6.74] days vs 4.66 [IQR 2.94-8.17] days; = .74). Hyperglycemia occurred at a higher rate in patients receiving ≤50% of their home basal insulin dose (97.6% vs 89%; = .02). No differences were observed in hypoglycemic events between those patients receiving ≤50% and >50% of their home basal insulin.

摘要

美国糖尿病协会指南建议,在非重症监护病房环境中,对于接受禁食(NPO;无经口摄入)的2型糖尿病(T2DM)患者,采用基础胰岛素联合校正剂量或基础胰岛素治疗方案。在围手术期,建议使用60%至80%的长效胰岛素或一半剂量的早晨中性鱼精蛋白锌胰岛素。本研究的目的是确定禁食期间胰岛素依赖型T2DM住院患者基础胰岛素剂量减少的影响。这项回顾性单中心研究评估了入住非重症监护病房的患者。将给予超过50%的家庭基础胰岛素与给予≤50%的家庭基础胰岛素进行比较。主要结局是低血糖事件(血糖[BG]<70mg/dL)的差异。次要结局包括比较严重低血糖事件(BG<40mg/dL)、高血糖事件(BG>180mg/dL)和住院时间(LOS)。纳入了258例患者,其中85例和173例患者分别接受了≤50%和>50%的家庭基础胰岛素剂量。低血糖(21.2%对21.4%;P = 0.97)、严重低血糖(1.2%对2.9%;P = 0.67)和住院LOS(3[四分位间距2.13 - 6.74]天对4.66[四分位间距2.94 - 8.17]天;P = 0.74)方面无显著差异。接受≤50%家庭基础胰岛素剂量的患者高血糖发生率更高(97.6%对89%;P = 0.02)。接受≤50%和>50%家庭基础胰岛素的患者在低血糖事件方面未观察到差异。

相似文献

1
Evaluation of Basal Insulin Dose Reductions in Hospitalized Patients With Diabetes While Unable to Eat.糖尿病住院患者无法进食时基础胰岛素剂量减少的评估
Hosp Pharm. 2020 Aug;55(4):246-252. doi: 10.1177/0018578719841029. Epub 2019 Apr 8.
2
Comparison of various basal insulin dose adjustments for inpatients while unable to eat.各种不能进食的住院患者基础胰岛素剂量调整的比较。
Int J Clin Pharm. 2022 Feb;44(1):72-78. doi: 10.1007/s11096-021-01314-2. Epub 2021 Aug 6.
3
EATING AND GLYCEMIC CONTROL AMONG CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS INTRAVENOUS INSULIN.危重症患者连续静脉输注胰岛素时的饮食和血糖控制。
Endocr Pract. 2020 Jan;26(1):43-50. doi: 10.4158/EP-2019-0095. Epub 2019 Aug 28.
4
Safety and efficacy of continuous insulin infusion in noncritical care settings.非重症监护环境中持续胰岛素输注的安全性和有效性。
J Hosp Med. 2010 Apr;5(4):212-7. doi: 10.1002/jhm.646.
5
CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS CONTINUED ON ORAL ANTIDIABETES MEDICATIONS IN THE HOSPITAL.住院继续使用口服降糖药物的 2 型糖尿病患者的临床特征。
Endocr Pract. 2020 Feb;26(2):167-173. doi: 10.4158/EP-2018-0524. Epub 2019 Sep 26.
6
Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.在2型糖尿病合并呼吸系统疾病的住院患者中,使用连续血糖监测比较甘精胰岛素与中性鱼精蛋白锌胰岛素作为基础胰岛素治疗糖皮质激素诱导的高血糖的疗效和安全性的随机临床试验。
Diabetes Res Clin Pract. 2015 Nov;110(2):158-65. doi: 10.1016/j.diabres.2015.09.015. Epub 2015 Sep 30.
7
BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA.基础-餐时胰岛素类似物方案与普通胰岛素治疗拉丁美洲2型糖尿病患者的随机对照试验
Endocr Pract. 2015 Jul;21(7):807-13. doi: 10.4158/EP15675.OR. Epub 2015 Jun 29.
8
Effect of a Standardized Treatment Panel on Hypoglycemic Events in Hospitalized Acute Hyperkalemic Patients Treated With Intravenous Regular Insulin.标准化治疗方案对接受静脉注射正规胰岛素治疗的住院急性高钾血症患者低血糖事件的影响。
Hosp Pharm. 2020 Aug;55(4):240-245. doi: 10.1177/0018578719841035. Epub 2019 Apr 4.
9
Evaluation of Insulin Use and Hypoglycemia in Hospitalized Elderly Patients.住院老年患者胰岛素使用情况及低血糖评估
Hosp Pharm. 2017 Dec;52(11):761-765. doi: 10.1177/0018578717735974. Epub 2017 Oct 12.
10
Comparison of Hypoglycemia and Safety Outcomes With Long-Acting Insulins Versus Insulin NPH in Pregestational and Gestational Diabetes.长效胰岛素与 NPH 胰岛素治疗孕前和妊娠期糖尿病的低血糖及安全性结局比较。
Ann Pharmacother. 2020 Jul;54(7):669-675. doi: 10.1177/1060028019897897. Epub 2020 Jan 1.

本文引用的文献

1
Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.择期手术糖尿病患者的围手术期血糖控制
JAMA. 2019 Jan 29;321(4):399-400. doi: 10.1001/jama.2018.20922.
2
15. Diabetes Care in the Hospital: .医院中的糖尿病护理: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S173-S181. doi: 10.2337/dc19-S015.
3
Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes.基础胰岛素剂量对非住院手术2型糖尿病患者血糖浓度的影响。
J Clin Anesth. 2017 Feb;36:184-188. doi: 10.1016/j.jclinane.2016.10.003. Epub 2016 Dec 5.
4
The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients.埃默里大学非心脏手术患者高血糖和糖尿病管理的围手术期算法
Curr Diab Rep. 2016 Mar;16(3):34. doi: 10.1007/s11892-016-0720-z.
5
Insulin before surgery (November 2013).术前胰岛素治疗(2013年11月)
Cleve Clin J Med. 2014 Jun;81(6):335. doi: 10.3949/ccjm.81c.06001.
6
Q: how should we manage insulin therapy before surgery?问:手术前我们应如何管理胰岛素治疗?
Cleve Clin J Med. 2013 Nov;80(11):702-4. doi: 10.3949/ccjm.80a.13055.
7
Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.比较基础-餐时与基础追加校正胰岛素方案用于 2 型糖尿病内科和外科住院患者的医院管理的随机研究:基础追加试验。
Diabetes Care. 2013 Aug;36(8):2169-74. doi: 10.2337/dc12-1988. Epub 2013 Feb 22.
8
Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients.住院、胰岛素治疗患者的低血糖与住院患者死亡率和住院时间的关系。
Curr Med Res Opin. 2013 Feb;29(2):101-7. doi: 10.1185/03007995.2012.754744. Epub 2012 Dec 14.
9
NHS Diabetes guideline for the perioperative management of the adult patient with diabetes.NHS 糖尿病诊治指南:成人糖尿病患者围手术期管理。
Diabet Med. 2012 Apr;29(4):420-33. doi: 10.1111/j.1464-5491.2012.03582.x.
10
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).随机研究基础-餐时胰岛素治疗在 2 型糖尿病患者普通外科手术(RABBIT 2 手术)中的住院管理。
Diabetes Care. 2011 Feb;34(2):256-61. doi: 10.2337/dc10-1407. Epub 2011 Jan 12.